Mirjana Wollner

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Charles M. Rudin, Mark M. Awad, Alejandro Navarro et al. · Journal of Clinical Oncology · 2020 · 759 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.

Zohar Keidar, Nissim Haim, Luda Guralnik et al. · PubMed · 2004 · 220 citations

Medicine, Oncology, Radiology +17

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)

Robin Cornelissen, Arsela Prelaj, Sophie Sun et al. · Journal of Thoracic Oncology · 2023 · 55 citations · Full text

Medicine, Oncology, Pharmacology +12